1-16059527-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_182623.3(FAM131C):c.529G>A(p.Glu177Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000217 in 1,609,564 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_182623.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FAM131C | NM_182623.3 | c.529G>A | p.Glu177Lys | missense_variant | 6/7 | ENST00000375662.5 | NP_872429.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FAM131C | ENST00000375662.5 | c.529G>A | p.Glu177Lys | missense_variant | 6/7 | 1 | NM_182623.3 | ENSP00000364814.4 | ||
FAM131C | ENST00000494078.1 | n.603G>A | non_coding_transcript_exon_variant | 5/6 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151650Hom.: 0 Cov.: 26
GnomAD3 exomes AF: 0.00000818 AC: 2AN: 244556Hom.: 0 AF XY: 0.00000751 AC XY: 1AN XY: 133160
GnomAD4 exome AF: 0.0000219 AC: 32AN: 1457914Hom.: 0 Cov.: 36 AF XY: 0.0000179 AC XY: 13AN XY: 724912
GnomAD4 genome AF: 0.0000198 AC: 3AN: 151650Hom.: 0 Cov.: 26 AF XY: 0.0000135 AC XY: 1AN XY: 74040
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 06, 2021 | The c.529G>A (p.E177K) alteration is located in exon 6 (coding exon 6) of the FAM131C gene. This alteration results from a G to A substitution at nucleotide position 529, causing the glutamic acid (E) at amino acid position 177 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at